|
Index of reports
> Cases resulting in hospitalization (124)
Below is the selection of adverse event reports related to Zetia (Ezetimibe) that includes cases resulting in hospitalization.
Reports 1 - 25 of 124 Next >>
Adverse event in 65 year old female receiving Zetia (Ezetimibe)
Reported by a physician from Japan on 2007-10-31
Patient: 65 year old female
Adverse reactions / side effects: Hepatic Function Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Crestor
Adverse event in 42 year old male receiving Zetia (Ezetimibe)
Reported by a pharmacist from United States on 2007-10-30
Patient: 42 year old male, weighing 83.9 kg (184.6 pounds)
Adverse reactions / side effects: Rhabdomyolysis
Adverse event resulted in: hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Coumadin; Coreg; Spironolactone
Adverse event in 60 year old male receiving Zetia (Ezetimibe)
Reported by a physician from Japan on 2007-10-26
Patient: 60 year old male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Hepatic Failure
Adverse event resulted in: hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Ursodiol; Phospholipids (Unspecified); Allopurinol; Pioglitazone Hydrochloride; Amlodipine Besylate
Adverse event in 65 year old male receiving Zetia (Ezetimibe)
Reported by a physician from Japan on 2007-10-25
Patient: 65 year old male
Adverse reactions / side effects: Mechanical Ileus, Gastroenteritis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Aspirin; Vasotec; Warfarin Potassium; Probucol
Adverse event in 71 year old male receiving Zetia (Ezetimibe)
Reported by a health professional (non-physician/pharmacist) from Spain on 2007-10-24
Patient: 71 year old male
Adverse reactions / side effects: Hyperkalaemia, Oedema
Adverse event resulted in: hospitalization
Suspect drug(s):
Chlorthalidone and Spironolactone
Administration route: Oral
Start date: 2006-01-01
End date: 2006-07-12
Rosiglitazone Maleate
Administration route: Oral
Start date: 2006-01-01
End date: 2006-07-12
Zetia
Administration route: Oral
Start date: 2006-01-01
End date: 2006-07-12
Adverse event in 50 year old male receiving Zetia (Ezetimibe)
Reported by a health professional (non-physician/pharmacist) from Sweden on 2007-10-24
Patient: 50 year old male
Adverse reactions / side effects: Rhabdomyolysis, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Candesartan Cilexetil
Administration route: Oral
Start date: 2007-04-01
Candesartan Cilexetil
Administration route: Oral
End date: 2007-08-06
Rosuvastatin Calcium
Administration route: Oral
Start date: 2006-01-01
Rosuvastatin Calcium
Administration route: Oral
Zetia
Administration route: Oral
Start date: 2006-01-01
Zetia
Administration route: Oral
Other drugs received by patient: Bisoprolol; Bisoprolol; Insulin; Enalapril Maleate; Enalapril Maleate; Isosorbide Mononitrate; Aspirin; Insulin Lispro
Adverse event in 56 year old female receiving Zetia (Ezetimibe)
Reported by a physician from Japan on 2007-10-23
Patient: 56 year old female
Adverse reactions / side effects: Pneumonia, Hepatitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Amlodipine Besylate; Amlodipine Besylate
Adverse event in 61 year old male receiving Zetia (Ezetimibe)
Reported by a physician from Netherlands on 2007-10-23
Patient: 61 year old male
Adverse reactions / side effects: Fibrosis, Hepatitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Lipitor
Start date: 2001-01-01
End date: 2005-03-24
Zetia
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2004-11-04
End date: 2005-03-24
Other drugs received by patient: Isosorbide Dinitrate; Phenprocoumon; Metoprolol Tartrate; Dipyridamole; Colestid
Adverse event in 50 year old male receiving Zetia (Ezetimibe)
Reported by a health professional (non-physician/pharmacist) from Sweden on 2007-10-22
Patient: 50 year old male
Adverse reactions / side effects: Rhabdomyolysis, Dizziness, Hypoaesthesia, Myoglobin Blood Increased, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Candesartan Cilexetil
Administration route: Oral
Start date: 2007-04-01
Candesartan Cilexetil
Administration route: Oral
End date: 2007-08-06
Rosuvastatin Calcium
Administration route: Oral
Start date: 2006-01-01
Rosuvastatin Calcium
Administration route: Oral
Zetia
Administration route: Oral
Start date: 2006-01-01
Zetia
Administration route: Oral
Other drugs received by patient: Bisoprolol Fumarate; Bisoprolol Fumarate; Insulin Human, Isophane; Enalapril Maleate; Enalapril Maleate; Isosorbide Mononitrate; Aspirin; Insulin Lispro
Adverse event in 49 year old male receiving Zetia (Ezetimibe)
Reported by a physician from United Kingdom on 2007-10-19
Patient: 49 year old male
Adverse reactions / side effects: Retinal Tear, Laboratory Test Abnormal, Fungal Skin Infection, Vitreous Detachment, Uveitis, Immunosuppression
Adverse event resulted in: hospitalization
Suspect drug(s):
Atorvastatin Calcium
Administration route: Oral
Indication: Blood Cholesterol Increased
Start date: 2004-01-01
Zetia
Administration route: Oral
Indication: Blood Cholesterol Increased
Start date: 2004-06-01
Other drugs received by patient: Viagra
Adverse event in 50 year old male receiving Zetia (Ezetimibe)
Reported by a health professional (non-physician/pharmacist) from Sweden on 2007-10-18
Patient: 50 year old male
Adverse reactions / side effects: Rhabdomyolysis, Dizziness, Hypoaesthesia, Myoglobin Blood Increased, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Candesartan Cilexetil
Administration route: Oral
Start date: 2007-04-01
Candesartan Cilexetil
Administration route: Oral
End date: 2007-08-06
Rosuvastatin Calcium
Administration route: Oral
Start date: 2006-01-01
Rosuvastatin Calcium
Administration route: Oral
Zetia
Administration route: Oral
Start date: 2006-01-01
Zetia
Administration route: Oral
Other drugs received by patient: Bisoprolol Fumarate; Bisoprolol Fumarate; Insulin Human, Isophane; Enalapril Maleate; Enalapril Maleate; Isosorbide Mononitrate; Aspirin; Insulin Lispro
Adverse event in 42 year old male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-10-15
Patient: 42 year old male, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Rhabdomyolysis, Coronary Artery Disease
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zetia
Administration route: Oral
Indication: Coronary Artery Disease
Start date: 2006-01-01
End date: 2007-08-16
Zetia
Administration route: Oral
Indication: Blood Cholesterol
Start date: 2006-01-01
End date: 2007-08-16
Other drugs received by patient: Coumadin; Coreg
Adverse event in 65 year old male receiving Zetia (Ezetimibe)
Reported by a physician from Japan on 2007-10-15
Patient: 65 year old male
Adverse reactions / side effects: Abdominal Pain, Mechanical Ileus, Diarrhoea, Anorexia, Gastrointestinal Sounds Abnormal
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Aspirin; Vasotec; Warfarin Potassium; Probucol
Adverse event in receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-10-05
Patient:
Adverse reactions / side effects: Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Lipitor
Zetia
Administration route: Oral
Indication: Blood Cholesterol
Adverse event in 42 year old male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-10-05
Patient: 42 year old male, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Rhabdomyolysis, Coronary Artery Disease
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zetia
Administration route: Oral
Indication: Coronary Artery Disease
End date: 2007-08-16
Zetia
Administration route: Oral
Indication: Blood Cholesterol
End date: 2007-08-16
Other drugs received by patient: Coumadin; Coreg
Adverse event in 57 year old female receiving Zetia (Ezetimibe)
Reported by a physician from Japan on 2007-10-03
Patient: 57 year old female
Adverse reactions / side effects: Contusion, Dizziness, Fall, Cold Sweat
Adverse event resulted in: hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Cetraxate Hydrochloride; Mecobalamin; Rosuvastatin Calcium; Zolpidem Tartrate
Adverse event in 53 year old female receiving Zetia (Ezetimibe)
Reported by a physician from Japan on 2007-10-01
Patient: 53 year old female
Adverse reactions / side effects: Loss of Consciousness
Adverse event resulted in: hospitalization
Suspect drug(s):
Probucol
Zetia
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2007-09-11
Other drugs received by patient: Amlodipine Besylate; Etizolam; Loxoprofen Sodium
Adverse event in 61 year old male receiving Zetia (Ezetimibe)
Reported by a physician from Germany on 2007-07-30
Patient: 61 year old male, weighing 70.0 kg (154.0 pounds)
Adverse reactions / side effects: Hepatocellular Damage
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Adverse event in 52 year old male receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-07-24
Patient: 52 year old male
Adverse reactions / side effects: Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Lipitor; Nonsteroidal Anti-Inflammatory Drug (Unspecified)
Adverse event in 76 year old male receiving Zetia (Ezetimibe)
Reported by a consumer/non-health professional from United States on 2007-07-23
Patient: 76 year old male, weighing 72.6 kg (159.7 pounds)
Adverse reactions / side effects: Osteoporosis, Upper Limb Fracture, Amnesia, Fall, Walking AID User, HIP Fracture, Dysarthria, Fatigue, Balance Disorder, Dementia Alzheimer's Type, Blood Cholesterol Increased, Blood Testosterone Decreased, Gait Disturbance, Asthenia, Hallucination
Adverse event resulted in: hospitalization
Suspect drug(s):
Lupron Depot
Dosage: depo-lupron injections1x mo. -every 4 mos im
Indication: Prostate Cancer
Start date: 1995-11-10
End date: 2007-03-03
Lupron Depot
Dosage: depo-lupron injections1x mo. -every 4 mos im
Indication: Prostate Cancer
Start date: 1995-11-10
End date: 2007-03-03
Zetia
Dosage: 1 a day
Administration route: Oral
Indication: Blood Cholesterol
Start date: 2002-12-14
End date: 2005-12-10
Zetia 10 MG Don't Remember
Dosage: zetia 1 a day po
Administration route: Oral
Indication: Blood Cholesterol
Start date: 2002-12-14
End date: 2005-12-10
Adverse event in 57 year old male receiving Zetia (Ezetimibe)
Reported by a individual with unspecified qualification from United States on 2007-07-19
Patient: 57 year old male, weighing 69.1 kg (152.0 pounds)
Adverse reactions / side effects: Angina Pectoris, Intestinal Obstruction
Adverse event resulted in: hospitalization
Suspect drug(s):
Acetylsalicylic Acid SRT
Administration route: Oral
Indication: Prophylaxis
Start date: 1986-01-01
End date: 2003-08-10
Amiodarone HCL
Administration route: Oral
Ciprofloxacin HCL
Administration route: Oral
Indication: Prophylaxis
Fluorouracil
Dosage: 500 mg/m2, day 1 and 8 cycle
Indication: Colorectal Cancer Metastatic
Start date: 2003-08-11
End date: 2003-08-11
Fluorouracil
Start date: 2003-08-18
End date: 2003-08-18
Irinotecan HCL
Dosage: 125 mg/m2 day 1 and 8 cycle
Indication: Colorectal Cancer Metastatic
Start date: 2003-08-11
End date: 2003-08-11
Irinotecan HCL
Start date: 2003-08-18
End date: 2003-08-18
Leucovorin Calcium
Dosage: 20 mg/m2, cycle 1, day 1, and day 8
Indication: Colorectal Cancer Metastatic
Start date: 2003-08-11
End date: 2003-08-18
Placebo
Administration route: Oral
Indication: Colorectal Cancer Metastatic
Start date: 2003-08-11
Protonix
Administration route: Oral
Toprol-XL
Administration route: Oral
Indication: Hypertension
Xanax
Administration route: Oral
Indication: Sleep Disorder
Zetia
Administration route: Oral
Indication: Blood Cholesterol
Adverse event in female receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-07-17
Patient: female, weighing 70.8 kg (155.8 pounds)
Adverse reactions / side effects: Polymyositis, Systemic Lupus Erythematosus, Fall, Radiculopathy
Adverse event resulted in: hospitalization
Suspect drug(s):
Enbrel
Indication: Rheumatoid Arthritis
Start date: 2003-07-01
End date: 2007-06-14
Zetia
Start date: 2006-01-01
End date: 2007-06-01
Other drugs received by patient: Levoxyl; Timolol Maleate; Lumigan
Adverse event in 58 year old male receiving Zetia (Ezetimibe)
Reported by a individual with unspecified qualification from United States on 2007-07-12
Patient: 58 year old male, weighing 69.0 kg (151.8 pounds)
Adverse reactions / side effects: Abdominal Pain, Angina Pectoris, Intestinal Obstruction, Constipation, Haemoglobin Decreased, Haematocrit Decreased, Enterovesical Fistula, Sleep Disorder, Colorectal Cancer Metastatic, Blood Cholesterol, Bladder Disorder, Blood Sodium Decreased, Arteriosclerosis, Hypertension
Adverse event resulted in: hospitalization
Suspect drug(s):
Amiodarone HCL
Dosage: total daily dose: 400 mg
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Aspirin
Dosage: total daily dose: 81 mg unit dose: 81 mg
Administration route: Oral
Indication: Prophylaxis
Start date: 1986-01-01
End date: 2003-08-10
Ciprofloxacin HCL
Dosage: total daily dose: 250 mg unit dose: 250 mg
Administration route: Oral
Indication: Prophylaxis
Fluorouracil
Indication: Colorectal Cancer Metastatic
Start date: 2003-08-11
End date: 2003-08-11
Fluorouracil
Start date: 2003-08-18
End date: 2003-08-18
Irinotecan HCL
Indication: Colorectal Cancer Metastatic
Start date: 2003-08-11
End date: 2003-08-11
Irinotecan HCL
Start date: 2003-08-18
End date: 2003-08-18
Leucovorin Calcium
Indication: Colorectal Cancer Metastatic
Start date: 2003-08-11
End date: 2003-08-18
Protonix
Dosage: total daily dose: 40 mg
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Toprol-XL
Dosage: total daily dose: 50 mg
Administration route: Oral
Indication: Hypertension
Xanax
Dosage: total daily dose: 0.5 mg
Administration route: Oral
Indication: Sleep Disorder
Zetia
Dosage: total daily dose: 10 mg
Administration route: Oral
Indication: Hypercholesterolaemia
Adverse event in 80 year old female receiving Zetia (Ezetimibe)
Reported by a physician from Japan on 2007-07-12
Patient: 80 year old female
Adverse reactions / side effects: Atrial Fibrillation
Adverse event resulted in: hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Adverse event in female receiving Zetia (Ezetimibe)
Reported by a physician from Israel on 2007-07-06
Patient: female
Adverse reactions / side effects: Upper Respiratory Tract Infection, Oedema Peripheral, Cardiac Failure Congestive
Adverse event resulted in: hospitalization
Suspect drug(s):
Cilazapril
Dexamethasone
Dosage: po
Administration route: Oral
Diltiazem HCL
Hydrochlorothiazide
Dosage: po
Administration route: Oral
Metformin HCL
Nifedipine
Zetia
Dosage: po
Administration route: Oral
Other drugs received by patient: Famotidine; Glyburide; Temozolomide
Page 1 Next >>
|
